When basal insulin is not enough: response to M Davidson.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Definition of Overbasalization.Clinical diabetes : a publication of the American Diabetes Association · 2025
   Article
2. Practicable Measurement and Identification of Overbasalization.Clinical diabetes : a publication of the American Diabetes Association · 2022
   Article
3. A Conversation on an Effective, Straightforward, Quantitative Approach to the Outpatient Use of Insulin.Diabetes spectrum : a publication of the American Diabetes Association · 2022
   Article
4. Clinical Overbasalization Revisited.Clinical diabetes : a publication of the American Diabetes Association · 2022
   Article
5. The Clinical Definition of Overbasalization.Clinical diabetes : a publication of the American Diabetes Association · 2021
   Article

Corrections and comments

• Comment on
  When basal insulin is not enough: A dose-response relationship between insulin glargine 100 units/mL and glycaemic control.2019
• Comment on
  Response to Umpierrez et al.2019

Authors and funding

6 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as